The Brent crude oil benchmark rose to a more than two-month high above $45 a barrel on Wednesday on hopes of an effective COVID-19 vaccine and an industry report showing U.S. crude inventories fell more than expected.
Brent was up $1.07, or 2.5%, at $44.68 by 1450 GMT after hitting a session high of $45.30 – the first time it has cleared the $45 threshold since early September.
